HALO Hybrid Fractional Laser
World's first hybrid fractional laser combining ablative + non-ablative
이 치료에 대해
HALO by Sciton is the world's first hybrid fractional laser, simultaneously delivering 2940nm Er:YAG ablative and 1470nm diode non-ablative wavelengths from the same handpiece. This achieves both surface renewal and deep collagen remodeling in a single treatment.
Combines ablative-level results with significantly reduced downtime compared to traditional ablative lasers. Established combination protocols with BBL™ (BroadBand Light).
작용 기전
2940nm ablative component precisely vaporizes damaged tissue (pigmentation, thickened keratin). 1470nm non-ablative component creates deep dermal coagulation zones, triggering HSP-mediated collagen remodeling. DTO™ provides real-time temperature control for safety and uniform results.
적응증
기대 효과
Single treatment equals 3-5 sessions of conventional fractional laser. 50-80% pigmentation improvement, significant pore reduction. Results continue improving over 3-6 months. Enhanced with BBL combination.
임상 근거
위험 및 부작용
Redness, swelling, micro-crusting (MEND) for 3-7 days. Rare PIH (especially Fitzpatrick III-VI). Sun protection essential. Transient herpes reactivation risk (prophylaxis recommended).